Substance / Medication

Ampicillin anhydrous

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

14
Total Trials
3
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Infective endocarditis byspecies: a systematic review.
Ioannou Petros, Baliou Stella, Papakitsou Ioanna et al. · J Chemother · 2023
PMID: 35383546Meta-Analysis
Consequences of Shigella infection in young children: a systematic review.
Libby Tanya E, Delawalla Miranda L M, Al-Shimari Fatima et al. · Int J Infect Dis · 2023
PMID: 36736579Meta-AnalysisFull text (PMC)
Antimicrobial resistance in sexually transmittedin men who have sex with men: A systematic review.
O'Flanagan Holly, Siddiq Mohammed, Llewellyn Carrie et al. · Int J STD AIDS · 2023
PMID: 36786731Meta-Analysis
The increasing antimicrobial resistance ofspecies among Iranian pediatrics: a systematic review and meta-analysis.
Baharvand Amirhossein, Molaeipour Leila, Alesaeidi Sogol et al. · Pathog Glob Health · 2023
PMID: 36794800Meta-AnalysisFull text (PMC)
The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases.
Meena Durga Shankar, Kumar Deepak, Sharma Mukesh et al. · Orphanet J Rare Dis · 2023
PMID: 37269006Meta-AnalysisFull text (PMC)
A systematic review of case reports of hepatic actinomycosis.
Chegini Zahra, Didehdar Mojtaba, Tabaeian Seidamir Pasha et al. · Orphanet J Rare Dis · 2021
PMID: 33931097Meta-AnalysisFull text (PMC)
Clinical aspects of abdominal actinomycosis: a systematic review.
Manterola Carlos, Grande Luis, Riffo-Campos Ángela L et al. · ANZ J Surg · 2020
PMID: 32729660Meta-Analysis
The diagnosis and management of pulmonary actinomycosis.
Boot Madison, Archer Jack, Ali Ishad · J Infect Public Health · 2023
PMID: 36801629Review
Fungal Lesions of the Oral Mucosa Diagnosis and Management.
Woods Tina R, White Jamie, Koutlas Ioannis · Oral Maxillofac Surg Clin North Am · 2023
PMID: 36805904Review
Cryptococcal meningoencephalitis with Actinomyces odontolyticus sepsis: a case report and literature review.
Huang Qingyu, Hong Zhuquan, Hong Quanlong · BMC Infect Dis · 2023
PMID: 37365493ReviewFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ampicillin anhydrous (substance)
SNOMED CT
1268946000
UMLS CUI
C0724526

Clinical Data

This intervention maps to 20 entities in the Healos knowledge graph.

20
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
14
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.